Mol. Cells 2010; 30(5): 455-460
Published online September 2, 2010
https://doi.org/10.1007/s10059-010-0130-z
© The Korean Society for Molecular and Cellular Biology
Correspondence to : *Correspondence: drkim@gsnu.ac.kr
Autophagy has been implicated in cardiac cell death dur-ing ischemia/reperfusion (I/R). In this study we investi-gated how propofol, an antioxidant widely used for anes-thesia, affects the autophagic cell death induced by the myocardial I/R injury. The infarction size in the myocar-dium was dramatically reduced in rats treated with propofol during I/R compared with untreated rats. A large number of autophagic vacuoles were observed in the cardiomyocytes of I/R-injured rats but rarely in I/R-injured rats treated with propofol. While LC3-II formation, an autophagy marker, was up-regulated in the I/R-injured myocardium, it was significantly down-regulated in the myocardial tissues of I/R-injured and propofol-treated rats. Moreover, propofol inhibited the I/R-induced expression of Beclin-1, and it accelerated phosphorylation of mTOR during I/R and Beclin-1/Bcl-2 interaction in cells, which indicates that it facilitates the inhibitory pathway of autophagy. These data suggest that propofol protects the autophagic cell death induced by the myocardial I/R injury.
Keywords autophagy, Beclin-1/Bcl-2 interaction, cell death, ischemia/reperfusion, propofol
Mol. Cells 2010; 30(5): 455-460
Published online November 30, 2010 https://doi.org/10.1007/s10059-010-0130-z
Copyright © The Korean Society for Molecular and Cellular Biology.
Hae Sook Noh, Il Woo Shin1, Ji Hye Ha, Young-Sool Hah2, Seon Mi Baek, and Deok Ryong Kim*
Department of Biochemistry, Gyeongsang National University School of Medicine, Jinju 660-751, Korea, 1Anesthesiology and Pain Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Korea, 2Clinical Research Institute of Gyeongsang National University, Jinju 660-751, Korea
Correspondence to:*Correspondence: drkim@gsnu.ac.kr
Autophagy has been implicated in cardiac cell death dur-ing ischemia/reperfusion (I/R). In this study we investi-gated how propofol, an antioxidant widely used for anes-thesia, affects the autophagic cell death induced by the myocardial I/R injury. The infarction size in the myocar-dium was dramatically reduced in rats treated with propofol during I/R compared with untreated rats. A large number of autophagic vacuoles were observed in the cardiomyocytes of I/R-injured rats but rarely in I/R-injured rats treated with propofol. While LC3-II formation, an autophagy marker, was up-regulated in the I/R-injured myocardium, it was significantly down-regulated in the myocardial tissues of I/R-injured and propofol-treated rats. Moreover, propofol inhibited the I/R-induced expression of Beclin-1, and it accelerated phosphorylation of mTOR during I/R and Beclin-1/Bcl-2 interaction in cells, which indicates that it facilitates the inhibitory pathway of autophagy. These data suggest that propofol protects the autophagic cell death induced by the myocardial I/R injury.
Keywords: autophagy, Beclin-1/Bcl-2 interaction, cell death, ischemia/reperfusion, propofol
Hee-Kyung Ahn, Yong Won Kang, Hye Min Lim, Inhwan Hwang, and Hyun-Sook Pai
Mol. Cells 2015; 38(10): 866-875 https://doi.org/10.14348/molcells.2015.0115Soyoung Kim, Jaeseok Han, Young-Ho Ahn, Chang Hoon Ha, Jung Jin Hwang, Sang-Eun Lee, Jae-Joong Kim, and Nayoung Kim
Mol. Cells 2022; 45(6): 403-412 https://doi.org/10.14348/molcells.2022.2010Yuan-Shen Chen, Wei-Chu Chuang, Hsiu-Ni Kung, Ching-Yuan Cheng, Duen-Yi Huang, Ponarulselvam Sekar, and Wan-Wan Lin
Mol. Cells 2022; 45(4): 257-272 https://doi.org/10.14348/molcells.2021.0193